A Cross-sectional Survey of Colorectal Cancer Patients in Different Age Groups

January 4, 2024 updated by: Wang Guiyu

A Cross-sectional Survey of Symptomatic Characteristics, Family History and Pathologic Features of Colorectal Cancer Patients in Different Age Groups

This study will help to determine the main clinical symptom differences between patients of different ages, discover the family genetic predisposition of patients of different ages, and obtain the differences in pathological characteristics of patients of different ages, so as to provide help and basis for more accurate and earlier prevention and treatment of colorectal cancer.

Study Overview

Status

Recruiting

Intervention / Treatment

Detailed Description

Colorectal cancer is one of the common and highly prevalent malignant tumors of the gastrointestinal system. Previous studies have found that there may be some differences in disease characteristics and prognosis of colorectal cancer patients at different ages, such as patients with early-onset colorectal cancer (age <50 years) tend to have a worse prognosis than patients with late-onset colorectal cancer (age ≥50 years). However, existing studies on the characteristics of colorectal cancer patients at different ages are not well studied to answer the differences between these patients and develop targeted diagnostic and treatment strategies. Cross-sectional survey research, which uses survey research to collect data on a characteristic group over a certain period of time and statistically analyzes the data to obtain the characteristics of a certain disease or a certain treatment strategy, is a more mature approach that is particularly suitable for the questions that need to be answered in this study. Investigators found that no similar studies have been registered and conducted by searching the official websites of the China Clinical Research Registry and Clinical Trial, and there is a lack of research data on the Chinese population. Therefore, investigators believe there is an urgent need for a cross-sectional survey to study the symptomatic characteristics, family history, and pathologic features of colorectal cancer patients. This study will help to determine the main clinical symptom differences between patients of different ages, discover the family genetic predisposition of patients of different ages, and obtain the differences in pathological characteristics of patients of different ages, so as to provide help and basis for more accurate and earlier prevention and treatment of colorectal cancer.

Study Type

Observational

Enrollment (Estimated)

430

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Yuliuming Wang, Dr.
  • Phone Number: +86-15765191796
  • Email: wylm3141@163.com

Study Locations

    • Heilongjiang
      • Harbin, Heilongjiang, China, 150086
        • Recruiting
        • The 2nd Affiliated Hospital of Harbin Medical University
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Colorectal cancer patients in different age groups

Description

Inclusion Criteria:

  1. Adults aged 18 years and older with a pathologic diagnosis of colorectal cancer;
  2. Undergoing surgical treatment of the primary lesion;
  3. Voluntary participation of patients.

Exclusion Criteria:

  1. Do not agree to participate in the survey or withdraw informed consent
  2. Patients did not receive surgical treatment or did not undergo pathologic examination

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Under 60 group
Colorectal cancer paitents aged under 60 years old ( do not include 60 years old)
60-69 group
Colorectal cancer paitents aged 60-69 years old
70-79 group
Colorectal cancer paitents aged 70-79 years old
80 and over group
Colorectal cancer paitents aged 80 and over 80 years old

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Characteristics of clinical symptoms
Time Frame: 2023.12-2024.10
Comparison of the characteristics of clinical symptoms in patients of different ages;
2023.12-2024.10
Family history
Time Frame: 2023.12-2024.10
Comparison of the probability of having a family history in patients of different age stages;
2023.12-2024.10
Pathological characteristics
Time Frame: 2023.12-2024.10
Comparison of pathological characteristics of patients at different age stages;
2023.12-2024.10

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Risk factors
Time Frame: 2024.09-2024.10
Analysis of risk factors for stage progression in colorectal cancer patients
2024.09-2024.10

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Study Chair: Ye Tian, Prof., Second Affiliated Hospital of Harbin Medical University Ethics Committee

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 12, 2023

Primary Completion (Estimated)

October 1, 2024

Study Completion (Estimated)

December 1, 2024

Study Registration Dates

First Submitted

October 9, 2023

First Submitted That Met QC Criteria

November 21, 2023

First Posted (Actual)

November 24, 2023

Study Record Updates

Last Update Posted (Actual)

January 5, 2024

Last Update Submitted That Met QC Criteria

January 4, 2024

Last Verified

January 1, 2024

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe